Eritema fijo medicamentoso inducido por ivermectina: un evento adverso raro
Ivermectin-induced fixed drug eruption: a rare adverse event (English)

Cómo citar

Mejía de Calona, A., & Henríquez Rivas, O. (2024). Eritema fijo medicamentoso inducido por ivermectina: un evento adverso raro. INNOVARE Ciencia Y Tecnología, 10(1), 36. Recuperado a partir de https://revistas.unitec.edu/innovare/article/view/153

Resumen

On January 2021, a 62-year-old woman complained of “allergy” in her forearm. She had taken generic ivermectin (IVM) 6mg per week as COVID-19 prophylaxis for two weeks before the eruption. She stopped the medication and improved, but symptoms reactivated after IVM was restarted (A). On examination, there was a 4 cm diameter erythematous violaceous plaque. There was improvement after treatment with oral prednisolone and topical betamethasone (B & C). The patient had presented paracetamol-related eruption in her tongue some years before. Physicians should be aware of ivermectin-induced fixed drug eruption, since this drug is being widely used during the COVID-19 pandemic.
Ivermectin-induced fixed drug eruption: a rare adverse event (English)
Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

Descargas

Los datos de descargas todavía no están disponibles.